RU92016313A - NEW ANALOGUES OF VITAMIN D, METHOD OF THEIR PRODUCTION, INTERMEDIATE CONNECTION, FORMCOMPOSITION AND METHOD OF TREATMENT - Google Patents

NEW ANALOGUES OF VITAMIN D, METHOD OF THEIR PRODUCTION, INTERMEDIATE CONNECTION, FORMCOMPOSITION AND METHOD OF TREATMENT

Info

Publication number
RU92016313A
RU92016313A RU92016313/04A RU92016313A RU92016313A RU 92016313 A RU92016313 A RU 92016313A RU 92016313/04 A RU92016313/04 A RU 92016313/04A RU 92016313 A RU92016313 A RU 92016313A RU 92016313 A RU92016313 A RU 92016313A
Authority
RU
Russia
Prior art keywords
formcomposition
vitamin
treatment
production
intermediate connection
Prior art date
Application number
RU92016313/04A
Other languages
Russian (ru)
Other versions
RU2126384C1 (en
Inventor
Оге Свенсгорд Бреттинг Клаус
Original Assignee
Лео Фармасьютикал Продакт Лтд.
А/с (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909017890A external-priority patent/GB9017890D0/en
Application filed by Лео Фармасьютикал Продакт Лтд., А/с (Левенс Кемиске Фабрик Продукционсактиесельскаб) filed Critical Лео Фармасьютикал Продакт Лтд.
Publication of RU92016313A publication Critical patent/RU92016313A/en
Application granted granted Critical
Publication of RU2126384C1 publication Critical patent/RU2126384C1/en

Links

Claims (1)

Изобретение относится к соединениям формулы (1), в которых X является водородом или гидроксилом, R1 и R2 обозначают водород или С1 - С6-углеводород, или взытые вместе с атомом углерода, содержащим группу X, образуют С3 - С8-карбоциклическое кольцо; Q является простой связью или С1 - С8-углеводородным ненасышенным бирадикалом; m = 0,1 или 2; R1, R2 и/или Q могут быть необязательно замещены, и их производным. Соединения обладают противовоспалительной и иммуномодуляторной активностью, а также высокой способностью вызывать дифференциацию и ингибирование нежелательной пролиферации некоторых клеток.The invention relates to compounds of formula (1) in which X is hydrogen or hydroxyl, R 1 and R 2 denote hydrogen or C 1 - C 6 -hydrocarbon, or taken together with the carbon atom containing the group X, form C 3 - C 8 - carbocyclic ring; Q is a simple bond or C 1 - C 8 hydrocarbon unsaturated biradical; m = 0.1 or 2; R 1 , R 2 and / or Q can be optionally substituted, and their derivative. The compounds have anti-inflammatory and immunomodulatory activity, as well as a high ability to cause differentiation and inhibition of unwanted proliferation of certain cells.
RU92016313A 1990-08-15 1991-07-11 Vitamin d analogs, process for preparation thereof, intermediate composition, and method for suppressing morbid states RU2126384C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909017890A GB9017890D0 (en) 1990-08-15 1990-08-15 Chemical compounds i
GB9017890.6 1990-08-15
GB9017890/6 1990-08-15
PCT/DK1991/000200 WO1992003414A1 (en) 1990-08-15 1991-07-11 Novel vitamin d analogues

Publications (2)

Publication Number Publication Date
RU92016313A true RU92016313A (en) 1996-01-10
RU2126384C1 RU2126384C1 (en) 1999-02-20

Family

ID=10680686

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92016313A RU2126384C1 (en) 1990-08-15 1991-07-11 Vitamin d analogs, process for preparation thereof, intermediate composition, and method for suppressing morbid states

Country Status (20)

Country Link
US (1) US5447924A (en)
EP (1) EP0543864B1 (en)
JP (1) JP3246914B2 (en)
KR (1) KR100203227B1 (en)
AT (1) ATE115562T1 (en)
AU (1) AU636510B2 (en)
CA (1) CA2078555C (en)
CZ (1) CZ286485B6 (en)
DE (1) DE69105981T2 (en)
DK (1) DK0543864T3 (en)
ES (1) ES2068601T3 (en)
FI (1) FI103791B1 (en)
GB (1) GB9017890D0 (en)
GR (1) GR3014922T3 (en)
IE (1) IE66241B1 (en)
LT (1) LT3666B (en)
LV (1) LV10089B (en)
RU (1) RU2126384C1 (en)
SK (1) SK281443B6 (en)
WO (1) WO1992003414A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062520C (en) * 1991-03-11 1998-08-11 Hector F. Deluca Synthesis of 1-alpha-hydroxy-secosterol compounds
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
US6291444B1 (en) 1993-06-16 2001-09-18 Wisconsin Alumni Research Foundation Treatment of t-cell immunodeficiencies with vitamin D compounds
US5880114A (en) * 1993-06-16 1999-03-09 Wisconsin Alumni Research Foundation Treatment of immune deficiency with vitamin D compounds
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
DE19519273A1 (en) * 1995-05-22 1996-11-28 Schering Ag Topical agents for the treatment and prophylaxis of alopecia
NO971934L (en) * 1996-05-23 1997-11-24 Hoffmann La Roche Fluorinated vitamin D3 analogues
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
MA26481A1 (en) * 1997-04-21 2004-12-20 Hoffmann La Roche ARYLSECOCHOLADIAN DERIVATIVES
WO1999003828A1 (en) * 1997-07-17 1999-01-28 F.Hoffmann-La Roche Ag Dihomo-seco-cholestanes with two unsaturated bones in the side chain
ES2196614T3 (en) * 1997-09-08 2003-12-16 Hoffmann La Roche ANALOGS OF 1-3-DIHIDROXI-20,20-DIALQUIL-VITAMIN D3.
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
AU762481C (en) 1998-03-27 2004-08-19 Oregon Health Sciences University Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
BRPI0213658A8 (en) 2001-10-19 2016-12-06 F Hoffmann La Roche Ltd METHOD FOR PREPARING A PREDETERMINED OR NON-DETERMINED ISOMERIC MIXTURE OF CYCLOSPORIN A ANALOGS MODIFIED IN THE 1-AMINO ACID RESIDUE, METHOD FOR PRODUCING A MIXTURE ENRICHED WITH E-ISOMER OR Z-ISOMER OF CYCLOSPORIN A ANALOGS MODIFIED IN THE 1-AMINO ACID RESIDUE, MIXTURE OF (E) AND (Z)-ISOMERS, COMPOSITION, METHOD FOR THE STEREOSE SELECTIVE SYNTHESIS OF THE Z-ISOMER OF ISATX247, METHOD FOR THE PREPARATION OF CYCLOSPORIN A ALDEHYDE
JP4512490B2 (en) * 2002-10-23 2010-07-28 レオ ファーマ アクティーゼルスカブ Vitamin D analogs, compositions comprising the analogs and uses thereof
AR041696A1 (en) 2002-10-23 2005-05-26 Leo Pharm Prod Ltd VITAMIN D ANALOG COMPOUNDS, COMPOSITIONS THAT INCLUDE SUCH ANALOG COMPOUNDS AND THEIR USE
US7351869B2 (en) * 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
ES2233209B1 (en) * 2003-11-28 2006-04-01 Laboratorios Viñas S.A. COMPUESTOS MONOHALOGENOVINILDERIVADOS DE VITAMINA D.
ES2234423B1 (en) * 2003-12-05 2006-03-01 Laboratorios Viñas, S.A. PROCEDURE FOR OBTAINING VITAMIN DERIVATIVES FROM MONOHALOGENOVINYL COMPOUNDS.
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
JP2008540513A (en) * 2005-05-10 2008-11-20 ダーミプソル リミテッド Compositions and methods for skin care
BRPI0715636A2 (en) * 2006-08-29 2013-07-02 Teva Pharma stable pharmacologically active compositions including low ph compatibility vitamin D and corticosteroid-containing compounds
CR20170434A (en) 2009-01-27 2017-11-21 Berg Llc VITAMIN D3 AND ANALOGS OF THE SAME TO RELIEF SECONDARY EFFECTS ASSOCIATED WITH CHEMOTHERAPY. (Divisional 2011-0445)
EP3603646B1 (en) 2009-08-14 2024-04-03 BPGbio, Inc. Vitamin d3 and analogs thereof for treating alopecia
KR101853518B1 (en) 2010-10-25 2018-04-30 데이진 화-마 가부시키가이샤 23-yne-vitamin d3 derivative
KR20160013201A (en) 2013-05-29 2016-02-03 버그 엘엘씨 Preventing or mitigating chemotherapy induced alopecia using vitamin d
WO2017209934A1 (en) 2016-05-13 2017-12-07 Case Western Reserve University Autophagy activators for treating or preventing skin injury

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (en) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd 1alpha, 25-dihydroxy-26,27-dimethylvitamin d3
JPS6172652A (en) * 1984-09-14 1986-04-14 Asahi Glass Co Ltd Calcium phosphate-based crystalline glass for dental material
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
JPS6253960A (en) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd Vitamin d3 derivative
WO1987000834A1 (en) 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
WO1987003282A1 (en) * 1985-11-21 1987-06-04 Taisho Pharmaceutical Co., Ltd. Vitamin d3 derivative
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
WO1989010351A1 (en) 1988-04-21 1989-11-02 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis Novel vitamin d analogues
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5053401A (en) 1989-02-28 1991-10-01 Chugai Seiyaku Kabushiki Kaisha Osteogenesis promotion with use of vitamin d derivatives
US4948789A (en) 1989-03-28 1990-08-14 Chugai Seiyaku Kabushiki Kaisha Suppression of parathyroid hormone synthesis and secretion
EP0398217B1 (en) * 1989-05-18 1994-01-12 F. Hoffmann-La Roche Ag Dehydrocholecalciferol derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (en) * 1990-04-06 1991-10-10 Schering Ag 24-OXA DERIVATIVES IN THE VITAMIN D SERIES
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Similar Documents

Publication Publication Date Title
RU92016313A (en) NEW ANALOGUES OF VITAMIN D, METHOD OF THEIR PRODUCTION, INTERMEDIATE CONNECTION, FORMCOMPOSITION AND METHOD OF TREATMENT
DK165003C (en) -chlorosulfate
ES2131207T3 (en) AMIDAS DERIVATIVES OF VALPROIC ACID AND 2-VALPROENOIC ACID AND ITS USE AS ANTICONVULSIVES.
RU94046411A (en) Derivatives of vitamin d, method of their synthesis, pharmaceutical composition based on thereof and method of its preparing, treatment method
ATE36699T1 (en) QUINONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL COMPOSITION.
HU896048D0 (en) Process for producing 7-substituted hept-6-ene acid and heptanic acid derivatives as well as their intermediaires
ES8801242A1 (en) Anticonvulsant dioxolane methane sulfamates.
ES8504737A1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions.
EP0366041A3 (en) Imido-percarboxylic acids
AU6016590A (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
DE3781879T2 (en) ANTHRACYCLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS.
DK7286A (en) OCTAHYDROINDOLIZINER
FI870460A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA 5-SUBSTITUERADE OKTAHYDROINDOLIZINDERIVAT OCH VID FOERFARANDET ANVAENDBARA MELLANPRODUKTER.
JPS5699480A (en) Preparation of pyridopyrimidine derivative
NO164170C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-BENZHYDRYL-4-CINNAMYL-PIPERAZINE DERIVATIVES.
JPS57171965A (en) Novel prostaglandin intermediate and its preparation
EP0124252A3 (en) Double ester of 16beta-ethylestran-17beta-ol derivatives
AU542419B2 (en) 17-amino-16-hydroxy steroids of the androstane and oestrane series
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
JPS57139086A (en) Ethylene glycol derivative
ES2009283A6 (en) Aminoacylates of glycerol acetal